NextPlat Reports 66% Net Loss Reduction and 35% Gross Margin in Q3 2026
Found this article helpful?
Share it with your network and spread the knowledge!

NextPlat Corp. (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions, reported third-quarter 2026 revenue of approximately $10.5 million, compared with $13.8 million in the prior-year period. The decline reflected lower pharmacy reimbursement rates and retail prescription volumes. Despite the revenue decrease, gross margin improved to approximately 35% from 19.9%, while net loss attributable to common stockholders narrowed 66% to approximately $700,000, or $0.28 per diluted share, from $2.2 million, or $0.84 per diluted share.
Pharmacy contract revenue increased 300% to approximately $2.4 million, driven by growth in higher-margin 340B services, while e-commerce revenue rose 3% to approximately $3.8 million. The company ended the quarter with approximately $11.2 million in cash and $13.5 million in working capital, with no material unsecured debt. NextPlat continued expanding its healthcare operations through the acquisition of Scott’s Pharmacy near Pensacola, Florida, and the opening of a new Jacksonville location. The company also plans to launch a nationwide medication fulfillment website in the fourth quarter, providing consumers across all 50 states with online access to prescription and over-the-counter healthcare products. Management expects contributions from its expanded pharmacy network and new contracted services to support future growth. To view the full press release, visit https://ibn.fm/8alUs.
For Texas businesses and investors, NextPlat’s performance underscores the potential of healthcare and technology convergence. The 300% growth in pharmacy contract revenue highlights the value of specialized services like 340B, which can drive profitability even when overall revenue declines. The company’s improving gross margin and reduced net loss signal operational efficiency gains that could serve as a model for other consumer products and services firms in the state. Moreover, the planned nationwide medication fulfillment website positions NextPlat to capture a larger share of the growing e-commerce healthcare market, potentially benefiting Texas-based partners and customers. As NextPlat continues to expand its pharmacy network, its progress will be closely watched by industry observers. The latest news and updates relating to NXPL are available in the company’s newsroom at https://ibn.fm/NXPL. This announcement was distributed through InvestorWire, a specialized communications platform that is part of the Dynamic Brand Portfolio at IBN, which provides editorial syndication to 5,000+ outlets and other services. For full terms of use and disclaimers, see https://www.InvestorWire.com/Disclaimer.
